Henry Schein, Inc. (NASDAQ:HSIC) Receives $78.89 Average Price Target from Analysts

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have been assigned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $78.89.

A number of equities analysts recently issued reports on HSIC shares. UBS Group decreased their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. JPMorgan Chase & Co. lowered their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Barrington Research restated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. Finally, Robert W. Baird lowered their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th.

Henry Schein Trading Up 1.8 %

NASDAQ HSIC opened at $75.08 on Friday. The stock has a market cap of $9.36 billion, a P/E ratio of 30.90, a PEG ratio of 2.12 and a beta of 0.87. The company’s fifty day simple moving average is $70.89 and its 200-day simple moving average is $69.73. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period in the prior year, the company posted $1.32 EPS. The business’s revenue was up .4% compared to the same quarter last year. Equities research analysts predict that Henry Schein will post 4.78 EPS for the current fiscal year.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 22.65 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Henry Schein

Hedge funds have recently bought and sold shares of the business. American Century Companies Inc. increased its holdings in shares of Henry Schein by 3.1% during the 2nd quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after acquiring an additional 162,477 shares during the last quarter. FMR LLC raised its position in shares of Henry Schein by 7.8% in the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after purchasing an additional 237,888 shares during the period. Swedbank AB acquired a new stake in shares of Henry Schein in the first quarter worth $215,998,000. Southpoint Capital Advisors LP boosted its holdings in shares of Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after buying an additional 600,000 shares during the period. Finally, Nuance Investments LLC grew its stake in Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after buying an additional 414,748 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.